| |
|
|
| |
|
|
| |
David Leitenberg, MD, PhD
|
|
 |
Center of Excellence, Departments, and Programs
The Center for Cancer and Blood Disorders
Laboratory Medicine
Leukemia/Lymphoma Program
Children’s Research Institute (CRI)
Center for Cancer and Immunology Research
View CRI Profile for David Leitenberg
Specialties: Allergic and Immunologic Disorders, Leukemia, Non-Hodgkin Lymphoma, Primary Immunodeficiency Diseases
|
|
| Board Certifications |
American Board of Pathology
|
National Provider Identifier
 |
1710047394 |
|
| Practice Locations |
Children's National Medical Center - Main Hospital
111 Michigan Avenue, NW
Washington, DC
Phone: 202-476-5000
 
|
|
| Biography |
| David Leitenberg, MD, PhD, is the director of the Immunology Laboratory in the Division of Laboratory Medicine. |
|
| Education |
| Type | School | Location | Degree | Field of Study | Years | | Undergraduate Education | University of Vermont | Burlington, VT | Bachelor of Arts | | 1979 -1983 | | Medical School | University of Iowa College of Medicine | Iowa City, IA | Doctor of Medicine | | 1990 |
|
|
| Training |
| Type | Institution | Location | Position | Specialty | Years | | Residency Program | Yale New Haven Hospital | New Haven, CT | Resident | | 1990 - 1993 | | Fellowship Program | Yale University | New Haven, CT | Fellow | | 1993 - 1995 |
|
|
| National and International Recognition |
| Award | Institution | Event | Year | | Arthritis Investigator Award | Arthritis Foundation | | 1998 | | Research Scholar Grant | American Cancer Society | | |
|
|
| Affiliations and Memberships |
| Title | Institution | Committee / Section | Years | | Member | American Association of Immunologists | | |
|
|
| Publications |
Journal Article, Falahati, R., Leitenberg, D. (2008), Selective regulation of TCR signaling pathways in primary thymocytes by the CD45 tyrosine phosphatase, Journal of Immunology, 181, 6082-6091.
Journal Article, Shen, W., K. Stone, A. Jales, D. Leitenberg, S. Ladisch (2008), Inhibition of TLR Activation and Up-Regulation of IL-1R-Associated Kinase-M Expression by Exogenous Gangliosides, Journal of Immunology, 180, 4425-4432.
Journal Article, Leitenberg, D., Falahati, R., Lu, D., and Takeda (2007), CD45-associated protein regulates the response to low-potency T cell stimulation and promotes CD45 association with CD3/TCR and lck, Immunology, 121, 545-554.
Journal Article, Falahati, R., and D. Leitenberg (2007), Changes in the role of the CD45 Protein Tyrosine Phosphatase in Regulating of Lck Tyrosine Phosphorylation During Thymic Development, Journal of Immunology, 178, 2056-2064.
Journal Article, Gwinn, W., J. Damsker, R. Falahati, I. Okwumabua, A. Kelly-Welsh, A. Keegan, C. Vanpouille, J. Lee, L. Dent, D. Leitenberg, M. Bukrinsky and S. Constant (2006), Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention, Journal of Immunology, 177, 4870-4879.
Journal Article, Meloni-Ehrig, A.M., Tirado, C.A., Chen, K., Jahn, J., Suchan, S., Scheerle, J., Crosby, M.G., Meany, H., Seibel, N., Leitenberg, D., Heritage, D.W., Mowrey, P.N. (2005), Isolated del (14)(q21) in a case of preursor B-cell acute lymphoblastic leukemia, Cancer Genetics and Cytogenetics, 161, 1 , 82-85.
Journal Article, Tatari-Calderone, Z., Brogdon, J.L., Tinsley, K., Ramezani, A., Leitenberg, D. (2005), CD4-dependent regulation of activation-induced cell death promotes selection of Th2 effector cells, Journal of Immunology, 175, 5629-5636.
Journal Article, Shen, W., R. Falahati, R. Stark, D. Leitenberg, and S. Ladisch (2005), The modulation of CD4 T helper cell differentiation by ganglioside GD1a in vitro, Journal of Immunology, 175, 4927-4934.
For a more comprehensive list of publications for David Leitenberg, MD, PhD view the National Library of Medicine’s PubMed online database |
|
|
|
|
|
|
